NYSE · Financial · Insurance - Life · USA
Metlife Inc is a large cap company (market value between $10 billion and $200 billion) in the Insurance - Life industry.
MetLife delivers insurance products, retirement plans, workplace benefits and investment management to corporations, institutions and individuals across the United States, Asia, Latin America, Europe and the Middle East. Operating through multiple divisions, the company serves group benefits, retirement income solutions, regional markets, and institutional asset management.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Metlife Inc stock.
Overvalued: intrinsic value $71.52 per share, market price $99.58, margin of safety -39.2% (as of 2026-10-19).
Book value at 1.62x, the multiple a 13.2% return on equity justifies, blended with earnings, values the shares at $71.52; the price of $99.58 is 39% above that value.
Leak Score: 63/100 on 11 of 12 signals (Faint Leak).
17 more funds hold it; the full list is part of the paid plan.
All 18 Insurance - Life stocks
4 more in this industry show a wider margin of safety.
MET is overvalued (as of the 2026-10-19 close). Book value at 1.62x, the multiple a 13.2% return on equity justifies, blended with earnings, values the shares at $71.52; the price of $99.58 is 39% above that value.
$71.52 per share (as of the 2026-10-19 close), against a market price of $99.58. That is a margin of safety of -39.2%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
The price needs roughly the return the bank already earns. Return on equity the price needs: 17.5%. Return on equity it earns: 13.2%.
63 out of 100, which we rate "Faint Leak", on 11 of 12 value investing signals.